List of Gilead Palo Alto, Inc patents

List of Gilead Palo Alto, Inc patents

List of Cisco Systems patents

List of Packet Digital patents

List of NKT Photonics A/S patents

List of Techstars Class 312 - ABN AMRO Techstars 2022 T5 companies

List of companies in Better Capital (company)'s investment portfolio

Patents where

Current Assignee

Name

is

‌

Gilead Palo Alto, Inc

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 7662819 Pteridinone derivatives for use as stearoyl CoA desaturase inhibitors	Patent 7662819 was granted and assigned to Gilead Palo Alto, Inc on February, 2010 by the United States Patent and Trademark Office.		‌ Gilead Palo Alto, Inc		United States Patent and Trademark Office	7662819	February 16, 2010
	‌ US Patent 7795268 Method of treating hepatic disease using A	Patent 7795268 was granted and assigned to Gilead Palo Alto, Inc on September, 2010 by the United States Patent and Trademark Office.		‌ Gilead Palo Alto, Inc		United States Patent and Trademark Office	7795268	September 14, 2010
	‌ US Patent 7893066 Pyridol[2,3-B]pyrazinones for use as stearoyl CoA desaturase inhibitors	Patent 7893066 was granted and assigned to Gilead Palo Alto, Inc on February, 2011 by the United States Patent and Trademark Office.		‌ Gilead Palo Alto, Inc		United States Patent and Trademark Office	7893066	February 22, 2011
	‌ US Patent 7795269 A	Patent 7795269 was granted and assigned to Gilead Palo Alto, Inc on September, 2010 by the United States Patent and Trademark Office.		‌ Gilead Palo Alto, Inc		United States Patent and Trademark Office	7795269	September 14, 2010
	‌ US Patent 7776868 Substituted bicyclic and tricyclic thieno[2,3-d]pyrimidines as A	Patent 7776868 was granted and assigned to Gilead Palo Alto, Inc on August, 2010 by the United States Patent and Trademark Office.		‌ Gilead Palo Alto, Inc		United States Patent and Trademark Office	7776868	August 17, 2010
	‌ US Patent 7655638 Partial and full agonists of A	Patent 7655638 was granted and assigned to Gilead Palo Alto, Inc on February, 2010 by the United States Patent and Trademark Office.		‌ Gilead Palo Alto, Inc		United States Patent and Trademark Office	7655638	February 2, 2010
	‌ US Patent 7655637 N-pyrazole A	Patent 7655637 was granted and assigned to Gilead Palo Alto, Inc on February, 2010 by the United States Patent and Trademark Office.		‌ Gilead Palo Alto, Inc		United States Patent and Trademark Office	7655637	February 2, 2010
	‌ US Patent 7732595 Process for preparing an A	Patent 7732595 was granted and assigned to Gilead Palo Alto, Inc on June, 2010 by the United States Patent and Trademark Office.		‌ Gilead Palo Alto, Inc		United States Patent and Trademark Office	7732595	June 8, 2010
	‌ US Patent 7671192 Process for preparing an A	Patent 7671192 was granted and assigned to Gilead Palo Alto, Inc on March, 2010 by the United States Patent and Trademark Office.		‌ Gilead Palo Alto, Inc		United States Patent and Trademark Office	7671192	March 2, 2010
	‌ US Patent 7683037 Myocardial perfusion imaging method	Patent 7683037 was granted and assigned to Gilead Palo Alto, Inc on March, 2010 by the United States Patent and Trademark Office.		‌ Gilead Palo Alto, Inc		United States Patent and Trademark Office	7683037	March 23, 2010
	‌ US Patent 7601721 Substituted heterocyclic compounds	Patent 7601721 was granted and assigned to Gilead Palo Alto, Inc on October, 2009 by the United States Patent and Trademark Office.		‌ Gilead Palo Alto, Inc		United States Patent and Trademark Office	7601721	October 13, 2009
	‌ US Patent 7732453 Pyrido[2,3-B] pyrazin-3(4H)-ones for use as stearoyl CoA desaturase inhibitors	Patent 7732453 was granted and assigned to Gilead Palo Alto, Inc on June, 2010 by the United States Patent and Trademark Office.		‌ Gilead Palo Alto, Inc		United States Patent and Trademark Office	7732453	June 8, 2010
	‌ US Patent 7741331 A2B adenosine receptor antagonists	Patent 7741331 was granted and assigned to Gilead Palo Alto, Inc on June, 2010 by the United States Patent and Trademark Office.		‌ Gilead Palo Alto, Inc		United States Patent and Trademark Office	7741331	June 22, 2010
	‌ US Patent 7655636 Use of A2A adenosine receptor agonists	Patent 7655636 was granted and assigned to Gilead Palo Alto, Inc on February, 2010 by the United States Patent and Trademark Office.		‌ Gilead Palo Alto, Inc		United States Patent and Trademark Office	7655636	February 2, 2010
	‌ US Patent 7625881 Prodrugs of A	Patent 7625881 was granted and assigned to Gilead Palo Alto, Inc on December, 2009 by the United States Patent and Trademark Office.		‌ Gilead Palo Alto, Inc		United States Patent and Trademark Office	7625881	December 1, 2009

15 results

0 selected

15 results

0 selected